Clinical and immunological efficiency of different therapy schemes in patients with infectious mononucleosis caused by Epstein-Barr virus. J. V. N. Karazin Khark. Nat. Univ., Ser. Med. 2021;(43). doi:10.26565/2313-6693-2021-43-08